These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 21586272

  • 1. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
    Hiruma Y, Hirai T, Tsuda E.
    Biochem Biophys Res Commun; 2011 Jun 10; 409(3):424-9. PubMed ID: 21586272
    [Abstract] [Full Text] [Related]

  • 2. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM.
    J Bone Miner Res; 2000 Apr 10; 15(4):640-9. PubMed ID: 10780856
    [Abstract] [Full Text] [Related]

  • 3. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 10; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2001 Oct 10; 16(10):1787-94. PubMed ID: 11585342
    [Abstract] [Full Text] [Related]

  • 5. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
    Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H.
    J Exp Med; 2003 Apr 21; 197(8):1029-35. PubMed ID: 12707301
    [Abstract] [Full Text] [Related]

  • 6. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
    Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M.
    J Bone Miner Res; 2007 Oct 21; 22(10):1612-20. PubMed ID: 17576169
    [Abstract] [Full Text] [Related]

  • 7. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627
    [Abstract] [Full Text] [Related]

  • 8. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May 17; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 9. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
    Yamaguchi M, Uchiyama S.
    Int J Mol Med; 2004 Jul 17; 14(1):81-5. PubMed ID: 15202020
    [Abstract] [Full Text] [Related]

  • 10. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
    Takahashi N, Udagawa N, Suda T.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):449-55. PubMed ID: 10080918
    [Abstract] [Full Text] [Related]

  • 11. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 12. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 01; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N.
    Hum Pathol; 2005 Sep 01; 36(9):945-54. PubMed ID: 16153456
    [Abstract] [Full Text] [Related]

  • 14. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF, Lie A, Ransjö M.
    J Cell Biochem; 2006 Oct 01; 99(2):528-37. PubMed ID: 16639710
    [Abstract] [Full Text] [Related]

  • 15. c-myc is required for osteoclast differentiation.
    Battaglino R, Kim D, Fu J, Vaage B, Fu XY, Stashenko P.
    J Bone Miner Res; 2002 May 01; 17(5):763-73. PubMed ID: 12009006
    [Abstract] [Full Text] [Related]

  • 16. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR.
    Arthritis Rheum; 2000 Feb 01; 43(2):250-8. PubMed ID: 10693863
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y.
    J Bone Miner Res; 2000 Jul 01; 15(7):1321-9. PubMed ID: 10893680
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
    Takeshita S, Kaji K, Kudo A.
    J Bone Miner Res; 2000 Aug 01; 15(8):1477-88. PubMed ID: 10934646
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ, Athanasou NA.
    J Pathol; 2008 May 01; 215(1):56-66. PubMed ID: 18283716
    [Abstract] [Full Text] [Related]

  • 20. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 01; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.